Explore other Johns Hopkins Sites
 
 
 
 
Wilmer Eye Institute
 

Wilmer Residency Training

Residency Training:
Second-Year Rotations (PGY-3)

The second-year rotations are devoted primarily to subspecialty clinical services with supervision by full-time faculty at the various institutions. These rotations include: glaucoma, cornea/external disease, pediatrics/strabismus, medical retina, oculoplastics, cataract, and uveitis.  A substantial portion of the subspecialty rotations is devoted to learning ocular surgery and laser therapy. Residents maintain a continuity clinic in the Wilmer GES.

Glaucoma
Preceptors: Harry Quigley, Henry Jampel, David Friedman, Pradeep Ramulu

The resident on the Glaucoma Service performs works with all members of the faculty and has a weekly Glaucoma Clinic when patients referred through the General Eye Service (GES) are evaluated for surgery under the supervision of the faculty.  Residents are supervised by a faculty preceptor as they become proficient in glaucoma surgery (trabeculectomies, tube shunts, cyclodestructive procedures, and laser procedures).

Cornea
Preceptors: Peter McDonnell (Chairman), Walter Stark, Bert Jun, Esen Akpek, Robert Weinberg, Roy Chuck, Alissa Kim

The resident on the cornea/external disease rotation has the opportunity to work with all the department faculty members.  There is a broad-based exposure to patients with cataracts as well as various infectious, inflammatory, and degenerative corneal diseases.  Refractive surgery is performed with Drs. Chuck and Weinberg at Greenspring and cataract surgery is performed under the direction of Dr. Akpek, Dr. Jun, or the Chief Resident.

Pediatrics
Preceptors: David Guyton, Michael Repka, Cameron Parsa, Patrick Tong

This rotation includes muscle clinic in the Wilmer GES (supervised by the pediatric ophthalmology fellows and orthoptists), and two days of pediatrics / strabismus clinic and operating room experience per week.

Retina
Preceptors: Neil Bressler, Susan Bressler, Sharon Solomon, Morton Goldberg, Andrew Schachat, Diana Do, Quan Nguyen

The Retina Service rotation allows the resident to see a high volume of patients with diseases such as diabetic retinopathy, age-related macular degeneration and occlusive retinal vasculopathy.   Laser therapy and interpretation of diagnostic tests, such as fluorescein angiography and optical coherence tomography, are performed under the direction of the Retinal Vascular Center faculty. Fluorescein angiography conference takes place every Monday morning.

Oculoplastics
Preceptors:  Nick Iliff, Shannath Merbs, Michael Grant

The resident sees patients with the faculty in clinic and assists them in surgery.  One day per week is devoted to Oculoplastics Clinic, in which GES patients considering oculoplastic surgery are evaluated and necessary surgery is performed under the supervision of a faculty preceptor.  In addition, the oculoplastics resident manages patients with ocular trauma, such as lid lacerations and orbital fractures.

Uveitis/Consults
Preceptors:  James Dunn, George Peters, Jennifer Thorne, Sanjay Kedhar

The Uveitis rotation includes a full day of clinic with both Dr. Dunn and Dr. Peters.  Residents learn to diagnose and treat ocular inflammatory disorders.  The role of corticosteroid and immunosuppressant therapy is emphasized, along with techniques such as periocular and intravitreal drug injections.  Residents present articles at monthly journal club meetings attended by all the Uveitis faculty. There is also a monthly Uveitis Conference for discussion of particularly interesting patients.  Two days a week, the resident sees inpatient consultations.

Wyman Park Medical Center
Preceptors:  Saraswathy Ramanathan, James Dunn, Harry Randall (Retina) 

This second-year rotation is an outpatient facility in which residents see general eye clinic patients with the faculty.  During this rotation, residents perform 10-20 phacoemulsification procedures and other anterior segment surgery with Drs. Ramanathan and Dunn.

MORE:

 
 
 
 
Controversy Swirls Around Lucentis

Julia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration.

About John Hopkins - Find Out More

Out-of-State and International Patients - Find Out More

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

About Johns Hopkins Medicine | Patient Care | Education | Research | Health Information Library
Get Directions | Contact Us | Request an Appointment | Refer a Patient | Find a Doctor | Media Inquiries